Published by Coherent Market Insights
Posted on September 14, 2021
3 min readLast updated: February 10, 2026
Add as preferred source on Google
Regenerative medicine is a term that is being increasingly used to describe the use of technology to encourage the regeneration of damaged or dying tissues. This form of therapy has the potential to treat diseases such as cancer, heart disease, Alzheimer’s, Parkinson’s and even strokes. However, the advances in this field are still very much in the research stage and there is great potential for the field in the future.
The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/163
Key Market Drivers:
Increasing funding in education for regenerative medicine is expected to propel growth of the global regenerative medicine market over the forecast period. For instance, in August 2021, led by Wake Forest Institute for Regenerative Medicine, the National Science Foundation awarded US$ 441,028 to a group of local partners, to help develop a regional regenerative medicine educational network and create the skilled technical workforce for a field driven by science and engineering.
Moreover, increasing availability of regenerative medicine is also expected to aid in growth of the global regenerative medicine market. For instance, in July 2021, Unity Spine & Joint, a chiropractic and pain clinic based in the U.S., announced to offer regenerative medicine in Tempe and neighboring areas of Arizona.
Key Market Restraints:
Lack of skilled workforce is expected to hinder growth of the global regenerative medicine market. For instance, the National Science Board, U.S. called for the creation of a skilled technical workforce driven by science and engineering in its 2019 report, “The Skilled Technical Workforce: Crafting America’s Science and Engineering Enterprise.”
Covid-19 Impact Analysis
Mesenchymal stem cells, a part of regenerative medicine, can help reduce inflammatory symptoms and protect against cytokine storm, which critically contributes to the COVID-19 progression. Globally, as of 4:06pm CEST, 18 August 2021, there have been 208,470,375 confirmed cases of COVID-19, including 4,377,979 deaths, reported to WHO. Various studies have suggested that allogenic bone marrow mesenchymal stem cell-derived exosomes are safe, can restore oxygenation, downregulate cytokine storms, and reconstitute immunity in severe COVID-19 patients. Such scenario is expected to offer lucrative growth opportunities for players in the regenerative medicine market.
Key Takeaways
The regenerative medicine market is expected to exhibit a CAGR of XX % over the forecast period, owing to increasing number of regenerative medicine franchises. For instance, in June 2021, QC Kinetix, a regenerative medicine franchise in the U.S., launched two locations in the Tampa Bay area, Florida.
Among regions, Asia Pacific is expected to witness significant growth in the regenerative medicine market, owing to increasing investment in regenerative medicine studies. For instance, in June 2021, European Wellness Biomedical Group, through its educational arm, European Wellness Academy, signed a LOI with Zhifu People’s Government of Yantai City, Shandong Province, China, to establish the first International Biological Regenerative Medicine Education Centre in Shandong Province.
Top Key Players Include In Regenerative Medicine Market: Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer Holdings, Inc.
Buy This Research Study Report For Quick Access With Flat US $ 2000 Off@ https://www.coherentmarketinsights.com/promo/buynow/163
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Regenerative Medicine Market Robust Growth Predicted For Emerging Economies During the Forecast Period appeared first on Gatorledger.
Regenerative medicine refers to the use of technology to encourage the regeneration of damaged or dying tissues, offering potential therapies for various conditions.
Key drivers include increasing funding in education for regenerative medicine and the growing availability of regenerative therapies.
A significant challenge is the lack of a skilled workforce, which is expected to hinder market growth according to the National Science Board in the U.S.
Mesenchymal stem cells, part of regenerative medicine, have shown potential in reducing inflammatory symptoms related to COVID-19, highlighting the market's relevance during the pandemic.
The Asia Pacific region is anticipated to witness substantial growth due to increased investment in regenerative medicine studies.
Explore more articles in the Research Reports category
